Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in thedrug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said. ...
The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, ...
In his interaction with Chief Ministers of several states, Prime Minister Narendra Modi on Wednesday warned that the Covid-19 crisis has not yet been overcome, stressing the importance of prioritising administration of vaccines to every eligible chil ...
The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years. ...
The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. ...
The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children ...
Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for pri ...
